Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-07-23 00:00 CEST (UTC+2h)

bioequivalence of drug combination [Regulatives / Guidelines]

posted by Norah - Tunisia, 2018-04-02 12:29  - Posting: # 18630
Views: 986

Hello
I need your advice please regarding this :
if ever a drug combination (like candesartan hydrochlorothiazide) has demonstrated its BE with the princeps,
is it mandatory to perform study for candasertan alone (same pharmaceutical company, same dosage)

Thanks !

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,547 posts in 3,941 threads, 1,190 registered users;
online 17 (0 registered, 17 guests [including 15 identified bots]).

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed